Search research articles
Contact Us
Filters
Showing results (151-160 of 163) with videos related to
Page
of 17
Sort By:
Cancer Research
|
August 9, 2003
The biological and biochemical effects of CP-654577, a selective erbB2 kinase inhibitor, on human breast cancer cells
E Gabriella Barbacci, Leslie R Pustilnik, Ann Marie K Rossi, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
October 3, 2024
Prognostic Value of Echocardiographic Coupling Metrics in Systemic Sclerosis-Associated Pulmonary Vascular Disease
Abhishek Gami, Vivek P Jani, Hoda Mombeini, et al.
Circulation. Genomic and Precision Medicine
|
July 17, 2025
Cardiac Troponin C E135A Variant Impairs Myofilament Response to PKA Phosphorylation and Is Associated With Autosomal Dominant Dilated Cardiomyopathy With Diastolic Dysfunction
Maicon Landim-Vieira, Robin M Perelli, Michelle Rodriguez-Garcia, et al.
The Journal of Clinical Investigation
|
October 7, 2021
Inhibition of phosphodiesterase type 9 reduces obesity and cardiometabolic syndrome in mice
Sumita Mishra, Nandhini Sadagopan, Brittany Dunkerly-Eyring, et al.
The European Respiratory Journal
|
June 6, 2024
Poor cardiac output reserve in pulmonary arterial hypertension is associated with right ventricular stiffness and impaired interventricular dependence
Ilton M Cubero Salazar, Andrew C Lancaster, Vivek P Jani, et al.
Plos One
|
July 5, 2013
Antitumor Efficacy of the Dual PI3K/mTOR Inhibitor PF-04691502 in a Human Xenograft Tumor Model Derived from Colorectal Cancer Stem Cells Harboring a PIK3CA Mutation
Douglas D Fang, Cathy C Zhang, Yin Gu, et al.
Cancer Research
|
November 13, 2003
Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy
Jean S Beebe, Jitesh P Jani, Elisabeth Knauth, et al.
Cancer Research
|
October 19, 2007
Discovery and pharmacologic characterization of CP-724,714, a selective ErbB2 tyrosine kinase inhibitor
Jitesh P Jani, Richard S Finn, Mary Campbell, et al.
Science (New York, N.Y.)
|
April 23, 2026
Severe obesity in human HFpEF alters contractile protein function and organization
Vivek P Jani, Marcus Rhodehamel, Axel J Fenwick, et al.
Molecular Cancer Therapeutics
|
April 1, 2010
PF-03814735, an orally bioavailable small molecule aurora kinase inhibitor for cancer therapy
Jitesh P Jani, Joel Arcari, Vincent Bernardo, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 163) with videos related to
Sort By:
Page
of 17
Cancer Research
|
August 9, 2003
The biological and biochemical effects of CP-654577, a selective erbB2 kinase inhibitor, on human breast cancer cells
E Gabriella Barbacci, Leslie R Pustilnik, Ann Marie K Rossi, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
October 3, 2024
Prognostic Value of Echocardiographic Coupling Metrics in Systemic Sclerosis-Associated Pulmonary Vascular Disease
Abhishek Gami, Vivek P Jani, Hoda Mombeini, et al.
Circulation. Genomic and Precision Medicine
|
July 17, 2025
Cardiac Troponin C E135A Variant Impairs Myofilament Response to PKA Phosphorylation and Is Associated With Autosomal Dominant Dilated Cardiomyopathy With Diastolic Dysfunction
Maicon Landim-Vieira, Robin M Perelli, Michelle Rodriguez-Garcia, et al.
The Journal of Clinical Investigation
|
October 7, 2021
Inhibition of phosphodiesterase type 9 reduces obesity and cardiometabolic syndrome in mice
Sumita Mishra, Nandhini Sadagopan, Brittany Dunkerly-Eyring, et al.
The European Respiratory Journal
|
June 6, 2024
Poor cardiac output reserve in pulmonary arterial hypertension is associated with right ventricular stiffness and impaired interventricular dependence
Ilton M Cubero Salazar, Andrew C Lancaster, Vivek P Jani, et al.
Plos One
|
July 5, 2013
Antitumor Efficacy of the Dual PI3K/mTOR Inhibitor PF-04691502 in a Human Xenograft Tumor Model Derived from Colorectal Cancer Stem Cells Harboring a PIK3CA Mutation
Douglas D Fang, Cathy C Zhang, Yin Gu, et al.
Cancer Research
|
November 13, 2003
Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy
Jean S Beebe, Jitesh P Jani, Elisabeth Knauth, et al.
Cancer Research
|
October 19, 2007
Discovery and pharmacologic characterization of CP-724,714, a selective ErbB2 tyrosine kinase inhibitor
Jitesh P Jani, Richard S Finn, Mary Campbell, et al.
Science (New York, N.Y.)
|
April 23, 2026
Severe obesity in human HFpEF alters contractile protein function and organization
Vivek P Jani, Marcus Rhodehamel, Axel J Fenwick, et al.
Molecular Cancer Therapeutics
|
April 1, 2010
PF-03814735, an orally bioavailable small molecule aurora kinase inhibitor for cancer therapy
Jitesh P Jani, Joel Arcari, Vincent Bernardo, et al.
Page
of 17